As of 2025-08-02, the Relative Valuation of Astellas Pharma Inc (4503.T) is 517.69 JPY. This relative valuation is based on P/E multiples. With the latest stock price at 1,576.50 JPY, the upside of Astellas Pharma Inc based on Relative Valuation is -67.2%.
The range of the Relative Valuation is 382.43 - 693.21 JPY.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 24.7x | 22.2x |
| Forward P/E multiples | 18.6x - 21.9x | 20.1x |
| Fair Price | 382.43 - 693.21 | 517.69 |
| Upside | -75.7% - -56.0% | -67.2% |
| Date | P/E |
| 2025-07-30 | 53.06 |
| 2025-07-29 | 53.44 |
| 2025-07-28 | 53.13 |
| 2025-07-25 | 52.69 |
| 2025-07-24 | 53.12 |
| 2025-07-23 | 53.04 |
| 2025-07-22 | 50.74 |
| 2025-07-18 | 51.65 |
| 2025-07-17 | 51.78 |
| 2025-07-16 | 51.30 |
| 2025-07-15 | 51.42 |
| 2025-07-14 | 51.33 |
| 2025-07-11 | 50.16 |
| 2025-07-10 | 49.10 |
| 2025-07-09 | 49.43 |
| 2025-07-08 | 48.68 |
| 2025-07-07 | 49.28 |
| 2025-07-04 | 50.00 |
| 2025-07-03 | 49.62 |
| 2025-07-02 | 49.62 |
| 2025-07-01 | 49.60 |
| 2025-06-30 | 50.51 |
| 2025-06-27 | 50.00 |
| 2025-06-26 | 49.39 |
| 2025-06-25 | 49.32 |
| 2025-06-24 | 49.59 |
| 2025-06-23 | 48.44 |
| 2025-06-20 | 48.20 |
| 2025-06-19 | 48.34 |
| 2025-06-18 | 49.21 |
| 2025-06-17 | 49.32 |
| 2025-06-16 | 49.41 |
| 2025-06-13 | 49.51 |
| 2025-06-12 | 50.51 |
| 2025-06-11 | 50.60 |
| 2025-06-10 | 50.55 |
| 2025-06-09 | 50.01 |
| 2025-06-06 | 49.78 |
| 2025-06-05 | 49.76 |
| 2025-06-04 | 50.48 |
| 2025-06-03 | 50.92 |
| 2025-06-02 | 50.80 |
| 2025-05-30 | 50.96 |
| 2025-05-29 | 50.41 |
| 2025-05-28 | 49.94 |
| 2025-05-27 | 50.09 |
| 2025-05-26 | 49.80 |
| 2025-05-23 | 49.67 |
| 2025-05-22 | 49.59 |
| 2025-05-21 | 49.21 |